Acute exposure of amyloid-β1-42 potentiates Ca2+ influx stimulated by nicotine or KCl

Life Sciences 2007 (2007) Proc Life Sciences, PC183

Poster Communications: Acute exposure of amyloid-β1-42 potentiates Ca2+ influx stimulated by nicotine or KCl

N. Innocent1, C. Hille2, S. Wonnacott1

1. Biology and Biochemistry, University of Bath, Bath, United Kingdom. 2. Neurology & GI CEDD, GlaxoSmithKline Pharmaceuticals, Harlow, United Kingdom.

View other abstracts by:


Amyloid-β1-42 (Aβ1-42) is believed to play a central role in the etiology of Alzheimer’s disease due to its accumulation in the brains of patients and its toxic effect on neurons. Reactive oxygen species, membrane perturbation and loss of ionic homeostasis, particularly that of Ca2+, have been implicated in the mechanism of toxicity (Mattson et al, 1992). Aβ1-42 interacts with a number of receptors and channels, including those permeable to Ca2+, such as nicotinic acetylcholine receptors (nAChR; Dougherty et al, 2003) and voltage operated calcium channels (VOCC; Ueda et al, 2003). Upon activation, nAChR allow Ca2+ and Na2+ entry. Amplification of this Ca2+ signal can occur by the depolarization that can open VOCC or by calcium–induced calcium release, depending on the nAChR subtype (Dickinson et al, 2006). Aβ1-42 has been variably reported to act as an agonist or an antagonist at nAChR (Liu and Wu, 2006). Aβ1-42 also directly affects VOCC to increase Ca2+ signals, when applied chronically (Ueda et al, 2003). This study investigates the acute effects of Aβ1-42 on intracellular Ca2+ produced from nAChR activation in the PC12 cell line. Aβ1-42 was treated with trifluoroacetic acid for 30 min to encourage oligomer formation, replicating the proposed toxic form. Toxicity was confirmed by treating PC12 cells with 10 μM Aβ1-42 for 24 h: this produced a 30 % decrease in MTT reduction when compared with vehicle-treated controls (n=6, p<0.001). When applied acutely to cells loaded with Fluo-3, Aβ1-42 (0.1 pM – 100 nM) alone produced no increase in intracellular Ca2+ signal, even in the presence of PNU 120596, an allosteric modulator used to amplify nAChR activity. This suggests that Aβ1-42 does not affect Ca2+ levels directly when applied acutely. However, a 10 min incubation with Aβ1-42 potentiated nicotine-evoked increases in Ca2+ (2.5-fold, n=3, p>0.05). This was fully blocked by mecamylamine (20 μM) and by the VOCC-antagonist verapamil (10 μM). An interaction with VOCC was supported by the potentiation of KCl-evoked increases in Ca2+ (1.9-fold, n=3, p<0.01) that was also blocked by verapamil (10 μM). This suggests that Aβ1-42 potentiates Ca2+ influx downstream of nAChR, by increasing the activity of VOCC.



Where applicable, experiments conform with Society ethical requirements.

Site search

Filter

Content Type